Worldwide concern over Zika virus (panel) and its temporal and geographical association with clusters of birth and neurological conditions escalated this week, with WHO declaring a Public Health Emergency of International Concern.
No doubt not wanting to repeat mistakes made in the west African Ebola outbreak, WHO was quick to raise the alarm. Briefing the WHO Executive Board on Jan 28, WHO DirectorGeneral Margaret Chan said Zika virus, now "spreading explosively" in the Americas, was deeply concerning for the organisation. Although a causal relation between infection with the virus and birth malformations and neurological syndromes has not been established, it is strongly suspected, Chan noted. "The possible links…have rapidly changed the risk profile of Zika, from a mild threat to one of alarming proportions. The increased incidence of microcephaly is particularly alarming, as it places a heart-breaking burden on families and communities."
She told the Executive Board that the concerns about Zika warranted convening an Emergency Committee under the International Health Regulations to advise on the appropriate level of international concern, recommend measures that should be undertaken in affected countries and elsewhere, and prioritise areas where research is most urgently needed. "The level of concern is high, as is the level of uncertainty. Questions abound. We need to get some answers quickly", she said.
The Emergency Committee met on Feb 1 and concluded that the recent cluster of microcephaly cases and other neurological disorders reported in Brazil, following a similar cluster in French Polynesia in 2014, was an "extraordinary event" and constituted a Public Health Emergency of International Concern.
On Feb 1, Chan said that WHO had accepted the committees' recommendation. She explained that declaring an emergency would allow for a coordinated global effort to get underway, enabling surveillance for microcephaly to be standardised and research to be intensified. Chan said that there was no reason to introduce restrictions to travel or trade, but pregnant women could consider delaying travel to affected areas or seek advice from their physician if they needed to travel and take precautionary measures against infection. 
At-risk population

Health concerns
Most people infected with Zika virus will not show any clear symptoms. However, in about one in five people, Zika causes a mild disease, with symptoms lasting from several days to a week. The most common symptoms are fever, rash, joint pain, and conjunctivitis. Severe disease requiring admission to hospital is uncommon.
The major concern in the present outbreak is related to the microcephaly clusters in Brazil, which have captured the attention of not only WHO but also the world's media. During October and November, 2015, the Ministry of Health in Brazil began reporting an unusual increase in cases of microcephaly, first, in the state of Pernambuco, located in the northeast of Brazil, then in three other states. On Nov 11, Brazil declared the situation a national public health emergency and began undertaking clinical, laboratory, and ultrasound analysis of affected newborn babies and their mothers. On Nov 17, WHO and PAHO issued an epidemiological alert, calling upon Member States to remain alert to the occurrence of similar events in their territories and to notify their occurrence through the channels established under the International Health Regulations.
Health authorities in Brazil have also reported an unusual increase in Guillain-Barré syndrome. The US Centers for Disease Control and Prevention (CDC) is currently working with public health officials in the country to investigate whether there is any link between Zika infection and the rare neurological disorder.
The other country to have seen similar neurological events in a Zika outbreak is French Polynesia. At the end of October, 2013, around 10 000 infections were registered in the Pacific Island nation, around 70 of which were severe cases, including neurological (Guillain-Barré syndrome, meningoencephalitis) or autoimmune (thrombocytopenic purpura, leucopenia) complications. Retrospectively, there were a small number of microcephaly cases in the country after the Zika outbreak, Aylward noted. However, both Brazil and French Polynesia have also experienced outbreaks of dengue and chikungunya, raising the possibility of co-infections.
Research pipeline
Aylward said that four types of studies were underway to try to answer some of the many questions about the Zika virus: case investigations and ecological, case-control, and cohort studies. He noted that Marie-Paule Kieny, WHO Assistant Director-General for Health Systems and Innovation, was leading a scoping exercise to assess the researchincluding diagnostics and vaccine research-being done worldwide. "Within a couple of weeks, WHO will have a good idea of where we are, what the research pipeline is", said Aylward. This knowledge will help the agency assess the merit of an accelerated agenda for product development. However, Aylward cautioned that a vaccine might not be available any time soon, noting that the timeframe for a dengue vaccine was many years.
In a briefing organised by the CDC on Jan 28, Anthony Fauci, Director of the National Institutes for Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), outlined the NIH's plans. "Within NIH, we have long supported research on viruses…With the emergence of the Zika virus, we are focusing efforts on several fronts", he said, including the development of animal models.
"We are also supporting, along with the CDC, the development of diagnostic platforms that can rapidly determine if a patient is infected with Zika or has been infected either recently or in the past, and distinguish it from other viruses, particularly dengue infection. Such diagnostic tools will be critical to reassure the unaffected pregnant women in areas where Zika is occurring and pregnant women returning from such areas."
He noted that researchers at NIAID are working on vaccine candidates to prevent Zika virus infection. Approaches being pursued include a DNA-based vaccine strategy, similar to the one used to develop a vaccine candidate against West Nile virus. NIAID was also evaluating a livevaccine approach, similar to the strategy used to develop a vaccine against dengue virus. However, echoing Aylward's sentiments, Fauci cautioned that "while these approaches are promising, it is important to understand we will not have a widely available safe and effective Zika vaccine this year and probably not in the next few years; although, we may be able to begin an early phase 1 clinical trial actually within this calendar year".
NIH has also issued a call to the research community to highlight its interest in funding a number of areas of research on Zika. In addition to accelerated research towards diagnostics, treatments, and vaccines, it is calling for basic research to understand Zika virus infection. NIH is already studying the evolution and emergence of the virus, and is planning studies of the pathogen's distribution and natural history in collaboration with the CDC. "NIH is actively pursuing answers to the numerous scientific questions related to Zika infection, and we are sharing this information in real time, refining our avenues for accelerating research", Fauci said.
Brazil's Ministry of Health has said that plans to develop a vaccine are also underway in the country. According to Pedro Vasconcelos, a doctor and researcher at Instituto Evandro Chagas, one of the three institutes in the country involved in the project, the vaccine will take 3-5 years to develop. The work is planned to start in February and will be done in collaboration with the University of Texas Medical Branch in Galveston, USA.
Speaking to The Lancet, Trudie Lang, head of the Global Health Network-a forum to help clinical researchers with trials-said that a digital platform for Zika research (www.zikainfection. tghn.org) has been launched by the International Severe Acute Respiratory and Emerging Infection Consortium and its international partners. "This is a resource that has been set up to enable research to get underway as quickly as possible. Here research tools and documents are being openly shared in order that studies can start as soon as possible and everyone collects data in the same way, so that it can then be pooled and shared."
Such an approach is important because there are many research questions that need to be answered quickly, she said.
Reporting problems
According to the latest epidemiological report by health authorities in Brazil, 4180 cases of microcephaly have been reported between November, 2015, and the third week of January, 2016. The northeast region has the highest number of notified cases, accounting for almost 80%, with Pernambuco reporting more than any other state.
However, some scientists in Brazil believe that the increase is not as high as it seems and might be even smaller when considering only those cases associated with Zika infection. Mauro de Freitas Rebelo, a professor and researcher at the Environmental and Molecular Biology Lab at the Federal University of Rio de Janeiro, for example, thinks that the fact that notification became mandatory in 2015 adds a bias that overestimates the increased rate of microcephaly in Brazil in the past year.
Additional problems lie in the fact that there are two different notification systems to report microcephaly cases in Brazil. The official notification system for all babies born in the country-SINESCproved too complex to report cases of microcephaly during the outbreak. To expedite notification, the Ministry of Health developed a new form-Registry of Events in Public Health (RESP)-and advised that suspected cases of Zika-related microcephaly be reported using this form. However, in another document issued in November, 2015, the Ministry of Health said that all cases of microcephaly should be reported in the RESP form.
This conflicting information has resulted in health authorities in each state developing their own interpretation of which system to use and how. For instance, the state of São Paulo, one of the largest in the country, only reports in the RESP registry microcephaly cases in which some evidence of a connection with infection by Zika is established.
Meanwhile, Alexandre Chieppe, superintendent of Environmental and Epidemiological Surveillance, State Secretary of Health, Rio de Janeiro, said that in the state of Rio de Janeiro, all cases of microcephaly, regardless of any connection with Zika, are notified in the RESP system. He explained that "a potential connection between microcephaly and infection by Zika during pregnancy depends on a comprehensive investigation that is done by a team of doctors and that requires a number of exams and analyses done later on".
Pernambuco
In Brazil, microcephaly was initially defined as head circumference below 33 cm and later corrected to 32 cm. Additionally, the state has not adopted either the RESP or the SINESC forms to report microcephaly and instead has created a third system for notification. The numbers of notified cases of microcephaly in different regions in Brazil, including the high number reported in Pernambuco, might therefore illustrate some of the disparities in the way microcephaly has been notified since 2015.
Underestimated?
While some experts believe the number of potential Zika-related microcephaly cases is overestimated, others think it is underestimated because many pregnant women do not have any symptoms when infected by Zika. Thus, many cases of microcephaly are not reported in the RESP registry because no connection with Zika virus has been established.
Additionally, Zika infection can only be confirmed by PCR and the current capacity for doing PCR tests for Zika diagnosis in Brazil is very limited. Only five laboratories are equipped to do the test and together they run no more than 100 tests per week. Even when PCR is available, the window of opportunity to do the test is very small as viral RNA is best identified in the blood of infected patients in the first few days after symptoms appear.
Reproductive issues
Even though the alarming number of microcephaly notifications is still limited to Brazil, in some countries in the Americas-Colombia, Jamaica, El Salvador, and Panamagovernments have advised women to postpone pregnancy. In Brazil, health authorities have not issued any official statement in this regard, although Cláudio Maierovitch, the director of the communicable disease surveillance department at the Ministry of Health, has stated that now is not a good time to get pregnant in high-risk areas.
There are initial reports that panic is spreading among pregnant women, with some wanting an abortion if they get infected by Zika during the first months of gestation. Abortion in Brazil is legal only in cases where pregnancy represents a risk for the life of the mother or is the result of rape. The law also allows for abortion when it is confirmed that the newborn will have a severe disease or congenital malformation. Because the link between Zika infection and microcephaly has not been confirmed, and the diagnosis of microcephaly can only be determined in the last weeks of pregnancy, at birth, or even later, some pregnant women infected with Zika have sought abortion illegally.
Losing battle
The Brazilian Government has launched several campaigns to mobilise the population against the mosquito and has deployed military forces to visit all households in the country to educate people on vector control. However, this strategy does not seem to be working and the Health Minister Marcelo Castro and the Brazilian President Dilma Rousseff have both announced that the country is losing the battle against the mosquito. Many experts believe that the population is not doing its part in stopping mosquitoes breeding in stagnant water, others say that there is little the population can actually do and that the government needs to invest in research projects to eradicate the mosquito. Strategies such as the releasing of Wolbachia-infected A aegypti mosquitoes have been done in Brazil since 2014 in a few small areas but no results have been announced.
As the world mobilises to answer the questions surrounding the Zika virus and congenital neurological conditions, Brazil is one country hoping that the answers will come soon.
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